{"disease":{"id":"psoriatic-arthritis-psa","name":"psoriatic arthritis psa"},"drugs":{"marketed":[{"drug_id":"tofacitinib-xeljanz","indication_name":"Psoriatic Arthritis (PsA)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tofacitinib (Xeljanz)","generic_name":"tofacitinib-xeljanz","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"JAK1 and JAK3","drug_class":"Janus Kinase Inhibitor","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05421442","title":"A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database","phase":"","overall_status":"COMPLETED","enrollment_count":38396,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06766552","title":"A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04806620","title":"Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Brain Inflammation Collaborative","has_results":false},{"nct_id":"NCT04541810","title":"A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis","phase":"","overall_status":"COMPLETED","enrollment_count":2369,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT07041112","title":"Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Juan Ruano Ruiz","has_results":false},{"nct_id":"NCT07188285","title":"Mass Spectrometry-based Immune Profiling in Autoimmune Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07087912","title":"Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":477,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT07277491","title":"Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity","phase":"","overall_status":"RECRUITING","enrollment_count":460,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT07148414","title":"A Study of SPY072 in Rheumatic Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":285,"lead_sponsor_name":"Spyre Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06666114","title":"Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab Environment","phase":"","overall_status":"COMPLETED","enrollment_count":232,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07160231","title":"REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Sint Maartenskliniek","has_results":false},{"nct_id":"NCT03419143","title":"Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants","phase":"","overall_status":"COMPLETED","enrollment_count":190,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07280702","title":"Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":128,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT07486843","title":"Preventing Structural Damage in Early Psoriatic Arthritis","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":108,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06918886","title":"Comparison of Liver Health in Psoriatic Arthritis Patients Using Anti-TNF or Anti-IL17 Treatments","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Bezmialem Vakif University","has_results":false},{"nct_id":"NCT06628206","title":"Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"LAPIX Therapeutics Inc.","has_results":false},{"nct_id":"NCT07111494","title":"Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":22,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}